Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Wockhardt Ltd Board/Management Information 2024

Feb 5, 2024

59231_rns_2024-02-05_edfa315f-ef60-4bd8-8747-69b5b2771c8b.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

5[th] February, 2024

Ref. No.: WOCK/SEC/SE/2023-24/067

==> picture [203 x 59] intentionally omitted <==

BSE Limited National Stock Exchange of India Limited Corporate Relations Department Exchange Plaza P J Towers Bandra Kurla Complex Dalal Street Bandra (E) Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 532300 NSE Symbol: WOCKPHARMA

Dear Sir/Madam,

Subject: Intimation of the Meeting of Board of Directors of Wockhardt Limited (‘the Company’)

Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, 14[th] February, 2024, inter-alia , to consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended 31[st] December, 2023.

In view of the above, the Trading window for dealing in the Shares of the Company, which was closed from 1[st] January, 2024 shall remain closed until 48 hours after the declaration of financial results on 14[th] February, 2024.

Kindly take the above information on record.

Thanking you,

For Wockhardt Limited

Rashmi Digitally signed by Rashmi Dinesh Dinesh Mamtura Date: 2024.02.05 Mamtura 16:20:20 +05'30' Rashmi Mamtura Company Secretary

==> picture [113 x 49] intentionally omitted <==

==> picture [513 x 32] intentionally omitted <==